Mercator Medical Spółka Akcyjna (MRC.WA)
Warsaw Stock Exchange · Financial statements, TTM figures and earnings dates
In fiscal year 2023 (ended December 31, 2023), Mercator Medical Spółka Akcyjna reported revenue of PLN 469.1M and net income of −PLN 19.7M. Annual financial statements are available for fiscal years 2020 to 2023, taken from the company's ESEF annual reports (IFRS).
Open interactive financials →Key financials
| PLN | FY2023 2023-12-31 | FY2022 2022-12-31 | FY2021 2021-12-31 | FY2020 2020-12-31 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | PLN 469.1M | PLN 542.5M | PLN 1.73B | PLN 1.83B |
| Operating income | −PLN 87.1M | −PLN 181.2M | PLN 463.4M | PLN 1.05B |
| Net income | −PLN 19.7M | −PLN 189.6M | PLN 446.9M | PLN 930.2M |
| Diluted EPS | −PLN 2.38 | −PLN 19.53 | PLN 43.95 | PLN 88.84 |
| Cash flow | ||||
| Operating cash flow | −PLN 86.0K | PLN 40.8M | PLN 503.0M | PLN 712.5M |
| Capital expenditure | PLN 39.1M | PLN 109.7M | PLN 176.8M | PLN 15.5M |
| Free cash flow | −PLN 39.2M | −PLN 68.9M | PLN 326.2M | PLN 697.0M |
| Balance sheet | ||||
| Cash and equivalents | PLN 217.3M | PLN 223.3M | PLN 339.6M | PLN 399.8M |
| Total assets | PLN 965.2M | PLN 1.08B | PLN 1.29B | PLN 1.29B |
| Total liabilities | PLN 105.5M | PLN 73.8M | PLN 143.3M | PLN 246.2M |
| Total debt | PLN 148.0K | PLN 211.0K | PLN 0 | PLN 686.0K |
| Shareholders' equity | PLN 862.1M | PLN 1.01B | PLN 1.14B | PLN 1.04B |
TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in PLN as reported; per-share data adjusted for stock splits.
Annual reports
More on the interactive page
The full MRC.WA page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.
Open MRC.WA financials →